JP2011505381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011505381A5 JP2011505381A5 JP2010536228A JP2010536228A JP2011505381A5 JP 2011505381 A5 JP2011505381 A5 JP 2011505381A5 JP 2010536228 A JP2010536228 A JP 2010536228A JP 2010536228 A JP2010536228 A JP 2010536228A JP 2011505381 A5 JP2011505381 A5 JP 2011505381A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- seq
- antibody
- segment
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99167907P | 2007-11-30 | 2007-11-30 | |
| US60/991,679 | 2007-11-30 | ||
| PCT/US2008/085196 WO2009073631A2 (en) | 2007-11-30 | 2008-12-01 | Antibodies to the pcrv antigen of pseudomonas aeruginosa |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011505381A JP2011505381A (ja) | 2011-02-24 |
| JP2011505381A5 true JP2011505381A5 (cg-RX-API-DMAC10.html) | 2012-01-26 |
| JP5781765B2 JP5781765B2 (ja) | 2015-09-24 |
Family
ID=40527381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010536228A Expired - Fee Related JP5781765B2 (ja) | 2007-11-30 | 2008-12-01 | シュードモナス・エルギノーサ（ＰｓｅｕｄｏｍｏｎａｓＡｅｒｕｇｉｎｏｓａ）のＰｃｒＶ抗原に対する抗体 |
Country Status (15)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| CN101031655A (zh) | 2004-07-26 | 2007-09-05 | 陶氏环球技术公司 | 通过株工程改进蛋白表达的方法 |
| US9394571B2 (en) * | 2007-04-27 | 2016-07-19 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| US9580719B2 (en) * | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| EP2248826B1 (en) | 2008-01-10 | 2013-06-12 | Shionogi&Co., Ltd. | Antibody directed against pcrv |
| US20100272736A1 (en) * | 2009-02-04 | 2010-10-28 | Kalobios Pharmaceuticals, Inc. | Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection |
| WO2010104052A1 (ja) | 2009-03-11 | 2010-09-16 | 塩野義製薬株式会社 | 抗緑膿菌作用を有するヒト化ＰｃｒＶ抗体 |
| EP2515935A4 (en) * | 2009-12-22 | 2013-08-28 | Kalobios Pharmaceuticals Inc | METHOD FOR TREATING STAPHYLOCOCCUS INFECTION IN A PATIENT WITH PSEUDOMONAS AERUGINOSA INFECTION WITH LOW PATHOGEN LEVEL |
| US8512950B2 (en) | 2010-07-21 | 2013-08-20 | Saint Louis University | Biolayer interferometry measurement of biological targets |
| AU2012267732A1 (en) | 2011-06-10 | 2014-01-09 | Medimmune Limited | Anti-Pseudomonas Psl binding molecules and uses thereof |
| WO2013070615A1 (en) | 2011-11-07 | 2013-05-16 | Medlmmune, Llc. | Combination therapies using anti- pseudomonas psl and pcrv binding molecules |
| JP6415987B2 (ja) | 2012-03-02 | 2018-10-31 | アブリンクス エン．ヴェー． | シュードモナス・エルギノーサのＰｃｒＶに結合する単一可変ドメイン抗体 |
| US20150284450A1 (en) * | 2012-11-06 | 2015-10-08 | Medimmune, Llc | Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| JP6966330B2 (ja) * | 2015-05-01 | 2021-11-17 | インヒブルクス，インコーポレイティド | Ｉｉｉ型分泌装置標的化分子 |
| JP6807606B2 (ja) | 2015-07-16 | 2021-01-06 | インヒブルクス インコーポレイテッド | 多価及び多重特異性ｄｒ５結合融合タンパク質 |
| SG11201809778TA (en) | 2016-05-05 | 2018-12-28 | Univ Pennsylvania | Dna antibody constructs for use against pseudomonas aeruginosa |
| WO2019178085A1 (en) | 2018-03-14 | 2019-09-19 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Il-13 receptor alpha 2 targeted, zetakine directed t cell immunotherapy |
| BR112021001683A2 (pt) | 2018-08-01 | 2021-05-04 | Cephalon, Inc. | anticorpos anti-cxcr2 e usos dos mesmos |
| CN113966343A (zh) * | 2019-06-11 | 2022-01-21 | 瑞泽恩制药公司 | 结合PcrV的抗PcrV抗体、包含抗PcrV抗体的组合物及其使用方法 |
| CN114072145B (zh) * | 2020-06-01 | 2024-06-11 | 北京三诺佳邑生物技术有限责任公司 | 特异性识别假单胞菌pcrv的抗体及其用途 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US108565A (en) * | 1870-10-25 | Improvement in snow-plows | ||
| US225552A (en) * | 1880-03-16 | Disintegrating-mill | ||
| US134098A (en) * | 1872-12-17 | Improvement in gage-cocks | ||
| GB8720833D0 (en) | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
| US5219998A (en) * | 1990-06-04 | 1993-06-15 | Levin Robert H | Yeast-derived epidermal growth factor |
| GB9012995D0 (en) | 1990-06-11 | 1990-08-01 | Celltech Ltd | Multivalent antigen-binding proteins |
| DE69726003T2 (de) | 1996-07-16 | 2004-08-26 | Andreas Plückthun | Immunglobulin-superfamilie domainen und fragmente mit erhöhter löslichkeit |
| US7141393B2 (en) | 1996-12-26 | 2006-11-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Interleukin-18-receptor proteins |
| US6309651B1 (en) * | 1998-11-25 | 2001-10-30 | Mcw Research Foundation | Method of and compositions for immunization with the pseudomonas V antigen |
| DE19918418C1 (de) * | 1999-04-23 | 2000-10-19 | Siegfried Mueller | Pflanzvorrichtung mit Halterung |
| AU2001238677A1 (en) | 2000-02-28 | 2001-09-12 | Idec Pharmaceuticals Corporation | Method for preparing anti-mif antibodies |
| JP4355786B2 (ja) * | 2001-01-26 | 2009-11-04 | エムシーダブリユー リサーチ フオンデーシヨン インコーポレーテツド | シュードモナスｖ抗原を用いる免疫化のための方法および組成物 |
| CA2374027A1 (en) | 2001-03-13 | 2002-09-13 | The Minister Of National Defence | Cloning, expression, sequencing, and functional enhancement of monoclonal scfv antibody against venezuelan equine encephalitis virus(vee) |
| ATE458006T1 (de) * | 2003-05-14 | 2010-03-15 | Kenta Biotech Ag | Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa |
| US7981843B2 (en) | 2004-01-20 | 2011-07-19 | Kalobios Pharmaceuticals, Inc. | Antibody specificity transfer using minimal essential binding determinants |
| PL2343380T3 (pl) * | 2004-11-16 | 2020-03-31 | Humanigen, Inc. | Wymiana kasety dla regionu zmiennego immunoglobuliny |
| US20090215165A1 (en) | 2005-05-20 | 2009-08-27 | James Rance | High-level expression of recombinant antibody in a mammalian host cell |
| EP1726650A1 (en) | 2005-05-27 | 2006-11-29 | Universitätsklinikum Freiburg | Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen |
| KR20080031383A (ko) | 2005-07-05 | 2008-04-08 | 베이커 메디컬 리서치 인스티튜트 | 항응고제 및 그의 용도 |
| JP2009531295A (ja) | 2006-02-22 | 2009-09-03 | ユニバーシティ オブ チューリッヒ | 自己免疫疾患又は脱髄疾患を処置するための方法 |
| US7649083B2 (en) | 2006-06-02 | 2010-01-19 | Aveo Pharmaceuticals, Inc. | Hepatocyte growth factor (HGF) binding antibody |
| US8221751B2 (en) | 2006-06-21 | 2012-07-17 | Oncotherapy Science, Inc. | Tumor-targeting monoclonal antibodies to FZD10 and uses thereof |
-
2008
- 2008-12-01 SG SG2012085239A patent/SG186017A1/en unknown
- 2008-12-01 CA CA2706732A patent/CA2706732A1/en active Pending
- 2008-12-01 KR KR1020107014345A patent/KR20100097719A/ko not_active Ceased
- 2008-12-01 WO PCT/US2008/085196 patent/WO2009073631A2/en not_active Ceased
- 2008-12-01 NZ NZ586357A patent/NZ586357A/xx not_active IP Right Cessation
- 2008-12-01 EP EP08856948A patent/EP2220117A2/en not_active Ceased
- 2008-12-01 MX MX2010005871A patent/MX2010005871A/es active IP Right Grant
- 2008-12-01 BR BRPI0819598A patent/BRPI0819598A2/pt not_active IP Right Cessation
- 2008-12-01 EA EA201000903A patent/EA201000903A1/ru unknown
- 2008-12-01 AU AU2008333985A patent/AU2008333985B2/en not_active Ceased
- 2008-12-01 JP JP2010536228A patent/JP5781765B2/ja not_active Expired - Fee Related
- 2008-12-01 US US12/325,806 patent/US8044181B2/en not_active Expired - Fee Related
- 2008-12-01 CN CN200880124705.7A patent/CN101910197B/zh not_active Expired - Fee Related
-
2010
- 2010-05-27 IL IL206036A patent/IL206036A0/en unknown
- 2010-05-28 ZA ZA2010/03852A patent/ZA201003852B/en unknown
-
2011
- 2011-10-11 US US13/271,146 patent/US8877191B2/en not_active Expired - Fee Related
-
2014
- 2014-10-08 US US14/509,437 patent/US20150030614A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5781765B2 (ja) | シュードモナス・エルギノーサ（ＰｓｅｕｄｏｍｏｎａｓＡｅｒｕｇｉｎｏｓａ）のＰｃｒＶ抗原に対する抗体 | |
| US12428473B2 (en) | Combination therapies using anti-pseudomonas PSL and PCRV binding molecules | |
| US8653242B2 (en) | Therapeutic antibodies against flagellated Pseudomonas aeruginosa | |
| AU2017204447B2 (en) | Anti-pseudomonas psl binding molecules and uses thereof | |
| US20150284450A1 (en) | Combination therapies using anti-pseudomonas psl and pcrv binding molecules | |
| US20100272736A1 (en) | Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection | |
| HK1201453B (en) | Combination therapies using anti- pseudomonas psl and pcrv binding molecules | |
| NZ722379B2 (en) | Combination therapies using anti-pseudomonas psl and pcrv binding molecules |